BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24886554)

  • 21. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway.
    Cui FC; Chen Y; Wu XY; Hu M; Qin WS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
    Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
    [No Abstract]   [Full Text] [Related]  

  • 24. miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2.
    Cao H; Liu Z; Wang R; Zhang X; Yi W; Nie G; Yu Y; Wang G; Zhu M
    Oncol Rep; 2017 Jan; 37(1):147-154. PubMed ID: 27878305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.
    Gao L; Shao X; Yue Q; Wu W; Yang X; He X; Li L; Hou F; Zhang R
    Oxid Med Cell Longev; 2021; 2021():9970272. PubMed ID: 34646428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma.
    Sun K; Jia Z; Duan R; Yan Z; Jin Z; Yan L; Li Q; Yang J
    Biochem Biophys Res Commun; 2019 Mar; 510(3):416-420. PubMed ID: 30717973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
    Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
    Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
    Zhang WB; Pan ZQ; Yang QS; Zheng XM
    Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
    Wang L; Wei WQ; Wu ZY; Wang GC
    Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.
    Zhang RL; Aimudula A; Dai JH; Bao YX
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32588875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
    Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
    Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice.
    Liu Y; Miao Y; Gao X; Wang YY; Wang H; Zheng YW; Zhao ZY
    Cell Physiol Biochem; 2018; 50(6):2365-2389. PubMed ID: 30423573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.